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Abstract
The C. elegans Hox gene egl-5 (ortholog of Drosophila Abdominal-B) is expressed in multiple tissues in the tail region and is involved in tail
patterning. In this study, we identify and clone the corresponding C. elegans orthologs of the components of the heterotrimeric transcription factor
NFY, nfya-1, nfyb-1 and nfyc-1 and demonstrate that mutations in these components result in the ectopic expression of egl-5 outside of its normal
expression domains. The NFYA-1 protein forms a complex with NFYB-1 and NFYC-1, specifically recognizing the CCAAT box. Mutating a
CCAAT box in the proximal promoter of egl-5 also leads to the derepression of egl-5, suggesting a direct role for the NFY complex in the
regulation of egl-5. In addition, we show that the NFY complex interacts with the MES-2/MES-6 PcG complex in Hox gene regulation. Thus, our
studies unravel a physiological function of NFY in establishing the spatially restricted expression pattern of egl-5.
© 2007 Elsevier Inc. All rights reserved.Keywords: NFY; egl-5; CCAAT box; Transcription; C. elegansHox genes, which encode conserved homeodomain-contain-
ing transcription factors, control the positional identities of cells
along the anterior–posterior axis (for a review, see Gellon and
McGinnis, 1998). Inappropriate expression of Hox genes leads
to homeotic transformations, whereby body structures are lost
or duplicated. Thus, identification of factors required for the
establishment of the spatially restricted expression domains of
Hox genes is critical for understanding how cellular positional
identities are specified during animal development. The C.
elegans Hox cluster consists of lin-39, ceh-13, mab-5 and egl-5
(orthologs of Drosophila Scr, labial, ftz and Abd-B, respec-
tively) (Aboobaker and Blaxter, 2003). Each C. elegans Hox
gene is expressed in restricted regions of multiple diverse
tissues and lineally unrelated cells and defines the region-
specific differentiation characteristics (Kenyon et al., 1997).
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doi:10.1016/j.ydbio.2007.05.021relative to other Hox clusters in animals (Aboobaker and
Blaxter, 2003), the expression pattern of Hox genes appears to
be regulated by several conserved regulation pathways. Thus C.
elegans offers a model to study how the restricted expression
pattern of Hox genes is established.
The expression of egl-5 is limited to the tail region and is
essential for structural patterning within its expression domains
(Ferreira et al., 1999). The expression of egl-5 in different cell
types is controlled by distinct regulatory pathways. For example,
the expression of egl-5 in the ventral neuroectoblast P12 is
activated by the combined actions of theWnt signaling and EGF
pathways (Jiang and Sternberg, 1998), while in the embryonic
muscle lineages, it is activated by VAB-7 (Ahringer, 1996). C.
elegans Hox genes, as in mammals, are also globally repressed
by Polycomb group (PcG) proteins (Zhang et al., 2003; for a
review, see Levine et al., 2004). Two evolutionarily conserved
PcG complexes, the ESC/E(Z) complex and the PRC1 complex,
both of which are involved in modulating repressive chromatin
structures, have been identified in fly and mammals (for a
review, see Levine et al., 2004). The C. elegans PcG-like
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functional properties with the PRC1 complex, is involved in the
global repression of Hox gene expression (Zhang et al., 2003;
Zhang et al., 2006). In sop-2 and sor-1 mutants, the C. elegans
Hox genes are globally derepressed, resulting in gross homeotic
transformations. Mutations in mes-2 and mes-6, which encode
the C. elegans ESC/E(Z) complex, however, only result in weak
ectopic expression of Hox genes (Ross and Zarkower, 2003).
The mechanism by which the C. elegans PcG complexes are
recruited to the Hox gene promoters remains unknown. Analysis
of the egl-5 promoter indicates that expression of egl-5 is under
the control of other negative regulatory factors because deleting
some DNA elements from its promoter results in ectopic
expression of egl-5 outside of its normal expression domains,
such as within the head region (Teng et al., 2004). Thus, the
complex expression pattern of egl-5 is the cumulative result of
the activities of multiple positive and negative regulatory factors.
NFY (nuclear factor Y) is one of the most abundant
transcription factors in eukaryotes and it specifically recognizes
the CCAAT box located in the promoters of genes (for a review,
see Mantovani, 1999). In mammalian cells, NFY is a ubiquitous
and constitutive heterotrimeric transcription factor, regulating
numerous genes involved in various biological processes (for a
review, see Mantovani, 1999). Consistently, the CCAAT box
has been shown to be one of the most widespread DNA
elements in the promoters of mammalian genes (for a review,
see Mantovani, 1999). NFY functions as both an activator and a
repressor, depending on its interacting cofactors. The activation
effect of NFY can be mediated through its direct interaction
with histone acetylases, such as p300 (Li et al., 1998), or by
facilitating the binding of TFIID to the core promoters (Frontini
et al., 2002; Coustry et al., 1998). NFY also recruits
transcriptional repressors to negatively regulate gene expres-
sion. For example, NFY directly recruits histone deacetylases
(HDACs) to repress the expression of the von Willebrand factor
in non-endothelial cells (Peng and Jahroudi, 2003). However,
the physiological function of NFY in multicellular organisms
remains to be determined due to the absence of an animal model
with abrogated endogenous NFY.
In this study, we demonstrate that the C. elegans NFY
complex (Cel-NFY) negatively regulates the expression of the
Hox gene egl-5. Mutations in components of the NFY complex
result in ectopic expression of egl-5 in many tissues, including
in the head region. A CCAAT box in the egl-5 promoter appears
to be required for the function of the NFY complex. The
repressive effect of NFY is greatly enhanced by the C. elegans
ESC/E(Z) complex, known as the MES-2/MES-6 complex.
Thus, our studies unravel a physiological function of NFY in
establishing the spatially restricted expression patterns of Hox
genes.
Materials and methods
Strains
Strains were maintained at 20 °C unless otherwise stated. All strains carry
the him-5(e1490) mutation, which gives rise to a high frequency of male self-
progeny. The following mutant alleles were used in this work: LGII: muIs16(mab-5∷gfp, dpy-20); LGV: bxIs14(pkd-2∷gfp, pha-1(+)); LGX: bxIs13(egl-
5∷gfp, lin-15(+)), nfya-1(bp4), nfya-1(bp5), and dpy-6(e14) unc-9(e101).
Identification, mapping and cloning of nfya-1
bxIs13(egl-5∷gfp) hermaphrodites were used for mutagenesis and their F2
progenies were screened. From 8000 genomes screened, 23 mutations with
expanded egl-5∷gfp expression domains were identified. Among these
mutations, three are new alleles of sop-2 and two are new alleles of sor-1.
bp4 and bp5 defined a new genetic locus. bp4 and bp5 caused same degree of
defects in ectopic expression of egl-5∷gfp in the head region.
Three-factor mapping placed nfya-1 between dpy-6 and unc-9 on linkage
group X. From the dpy-6+unc-9/+bp4+ cross, 72 out of the 96 Dyp non-Unc
recombinants and 32 out of the 121 Unc non-Dpy recombinants carried nfya-1
(bp4). bp5 was mapped in the same genetic region. From the dpy-6+unc-9/
+bp5+ cross, 34 out of the 50 Dyp non-Unc recombinants and 23 out of the 80
Unc non-Dpy recombinants carried bp5.
Cosmids from this region were injected into pha-1;nfya-1;bxIs13 mutants
together with transformation marker pBX1(pha-1(+)). The transformation
rescue was investigated by assaying ectopic expression of egl-5∷gfp and other
nfya-1 mutant defects in at least two stable transgenic lines. We found that the
PCR fragment containing T08D10.1 rescued defects in nfya-1(bp4) mutants. In
the three stable lines obtained, the average number of cells expressing egl-5:gfp
in the head region was reduced from 23.4 (n=29) in nfya-1(bp4) mutants to 2.4
(n=30) in nfya-1(bp4) mutants carrying the transgene. Other defects in nfya-1
(bp4) mutants, including abnormal rays, were also rescued by T08D10.1.
The nfya-1(bp4) and nfya-1(bp5) mutations were determined by sequencing
the PCR products from the corresponding genomic sequence.
RNA interference
Single-stranded RNA (ssRNA) was transcribed from the T7 and SP6-
flanked PCR templates. The PCR templates used for synthesizing RNA are:
nfya-1 (T08D10, nt 829–1543), nfyb-1 (W10D9, nt 17,749–18,224), nfyc-1
(F23F1, nt 16,964–17,709), nfya-2 (Y53H1A, nt 24,739–25,377), mes-2
(R06A4, nt 34,102–34,748), mes-6 (C09G4, nt 2870–3660), mes-3 (cDNA 1–
981) and mes-4 (Y2H9A, nt 4820–6200). The ssRNAs were then annealed and
injected into bxIs13, bxIs16 or nfya-1; bxIs13 animals. F1 progenies generated
4 h after injection were scored for phenotypes.
gfp reporter genes
The gfp reporters of nfya-1, nfyb-1 and nfyc-1 contain the coding sequence,
the promoter and the 3′ UTR of each gene (F55G7: nt 22,332 to T08D10: nt
3534, W10D9: nt 20,058–12,784, F23F1: nt 15,841–18,699, Y53H1A: nt
16,069–26,428 (missing introns IV to VII)). The GFP reporter was inserted at
the C-terminus of each gene. The reporter DNAwas then coinjected with pRF4
(rol-6) and at least two stable transgenic lines were analyzed. Mutant egl-5∷gfp,
carrying a mutated CCAAT site (CTAGC) (C08C3, nt 39,300–39,355) 86 bp
upstream of the translation start site, was constructed by PCR-based
mutagenesis. The mutation was then confirmed by sequencing.
GST pull-down and EMSA experiments
Constructs encoding GST fusion proteins of NFYA-1, NFYB-1, NFYC-1,
NFYA-2 and the conserved domain of each subunit (NFYA-1 (aa 293–368),
NFYA-2 (aa 114–205), NFYB-1 (aa 34–159) and NFYC-1 (aa 78–204)) were
made by subcloning the corresponding cDNA into pGEX-4T-1. The GST fusion
protein was overexpressed in E. coli strain BL21 and purified with a
glutathione–Sepharose™ 4B beads (Pharmacia). The corresponding cDNAs
cloned into pcDNA3 were used as templates for in vitro synthesis of 35S-labeled
proteins (TNT coupled Reticulocyte Lysate System, Promega). The GST fusion
protein (5 μg), 35S-labeled protein and 10 μl glutathione–Sepharose beads were
incubated in 500 μl binding buffer (25 mM Tris–Cl (pH 7.6), 150 mM NaCl,
1 mMDTT, 0.5% Triton X-100, 10% glycerol, 1 mM PMSF) for 2 h at 4 °C. The
reactions were then washed four times with 1 ml binding buffer. Bound proteins
were first analyzed by SDS–PAGE and then by autoradiograph.
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NFYC-1 were incubated with 32P-labeled probes (20,000 c.p.m.) in DNA-
binding buffer (100 mM Tris–HCl (pH 8.0), 300 mM KCl, 25 mMMgCl2, 20%
glycerol, 500 mg/ml BSA and 1 μg poly (dI-dC)). Reactions were placed on ice
for 20 min and then electrophoresed on 4% native TBE PAGE gel and analyzed
by autoradiograph.
Bioinformatic analysis
For the analysis of the distribution of CCAAT sites, the sequences of
promoter regions were obtained from WormBase. The score for each promoter
sequence was calculated using the position-weight matrix (PWM) method of
Bucher (1990): Score=100.0* (‘weighted sum’−min) / (max−min). A thresh-
old of 78 was used, as previously documented by Suzuki et al. (2001).
Results
Wild type nfya-1 represses the expression of Hox gene egl-5
To identify the components involved in regulating the
spatially restricted expression patterns of Hox genes in C.
elegans, strains carrying the Hox reporter gene egl-5∷gfp were
used to screen for mutants with expanded egl-5 expression
domains. In wild type early larvae, the expression of egl-5∷gfp
is confined to cells in the tail region (Ferreira et al., 1999 and
shown in Fig. 1A). Two alleles, bp4 and bp5, of a new genetic
locus (named nfya-1, as described below) were isolated as these
mutations resulted in the ectopic expression of egl-5 in the head
region and also in the mid-body region (Fig. 1B). Both bp4 and
bp5 appear to be null mutations (see below) and bp4was used in
this study. There was an average of 23.4 cells expressing egl-
5∷gfp in the head region in nfya-1(bp4) mutant animals
(Table 1). Furthermore, this misexpression of egl-5 in the head
regionwas first detected in the pretzel stage embryo in the nfya-1
mutants. In the male tail, the average number of cells expressing
egl-5∷gfp increased from 19.8 (n=11) in the wild type to 46.5
(n=16) in the nfya-1 mutant animals. Taken together, these
observations indicate that wild type nfya-1 is required for
repressing the expression of egl-5 outside of its normal
expression domains.
Mutations in nfya-1 lead to homeotic transformations
We examined whether homeotic transformations, phenoty-
pic readouts of misexpression of Hox genes, occurred in nfya-
1 males. In 2.1% (n=96) of nfya-1 males, compared to 0%
(nN1000) of wild type males, the ray-specific marker, pkd-
2∷gfp, was ectopically expressed in the anterior body region
rather than being confined to the posterior region (Figs. 1C,
D), indicating that the anterior seam cells adopted the fate of
the posterior seam cells in nfya-1 mutants. The low frequency
of ectopic rays in nfya-1 mutants is consistent with the
observation that ectopic expression of egl-5 only weakly leads
to the generation of rays by the anterior seam cells (Zhang et
al., 2003). egl-5 also specifies the characteristic identities of
rays derived from seam cell V6 (rays 2 to 6). In 91.3% (n=23)
of nfya-1 mutant male sides, ray 3 adopted the identity of and
fused with ray 4 (Figs. 1E, F). These homeotic transforma-
tions, as well as the increase in the number of cells expressingthe egl-5∷gfp in the nfya-1 mutant male tails (as described
above), suggest that endogenous egl-5 is ectopically expressed
in nfya-1 mutants.
Homeotic transformations were also observed in the ventral
cord of nfya-1 mutant males. In wild type males, six
serotonergic CP neurons, labeled by tph-1∷gfp, are generated
in the ventral cord, whose formation is specified by the Hox
gene lin-39 (Kenyon et al., 1997). One or two extra serotonergic
CP neurons were generated in 10.9% (n=102) of nfya-1 males,
suggesting that the expression domain of lin-39 was expanded
in nfya-1 mutants. These findings suggest that mutations in
nfya-1 cause homeotic transformations that result from the
deregulated Hox genes.
nfya-1 mutants have other developmental defects
Mammalian NFY is essential for cell viability and
proliferation (Bhattacharya et al., 2003). While nfya-1 mutants
were viable and fertile, they displayed several post-embryonic
developmental defects. nfya-1 mutants were uncoordinated
(Unc) and had protruding vulvae (Pvl). Furthermore, the
morphology of the nfya-1 male tail was grossly abnormal
(Figs. 1E, F). nfya-1 males lacked apparent spicules and a
hook, missed rays and had unretracted tail tips, much like the
“leptoderan” (Lep) mutants (Nguyen et al., 1999; Del Rio-
Albrechtsen et al., 2006). Mutations in nfya-1 also affected
the development of germ cells. The nfya-1 hermaphrodite
gonad contained fewer germ cells than the ones of wild type
animals (Figs. 1G, H). Consistently, nfya-1 mutants also had
a reduced brood size. nfya-1 mutants had an average of 31
offspring (n=15), compared to an average of 170 offspring
(n=14) in the wild type animals carrying egl-5∷gfp. The
number of sperm in males was also greatly reduced in nfya-1
mutants. In short, tissues affected in nfya-1 mutants are those
that, in the wild type, undergo extensive proliferation and
morphogenesis at post-embryonic stages. However, some of
the defects observed in nfya-1 mutants, such as the generation
of fewer germ cells and the grossly abnormal male tail,
cannot be readily attributed to the misregulation of egl-5,
suggesting that nfya-1 must also regulate the expression of
other targets.
nfya-1 encodes a C. elegans NFYA homolog
The nfya-1 locus was mapped to the linkage group X (see
Materials and methods) and was cloned by transformation
rescue (see Materials and methods and Supplemental Figure).
The PCR fragment containing a single predicted gene,
T08D10.1, fully rescued the nfya-1 mutant defects. T08D10.1
(RNAi) also led to the ectopic expression of egl-5 (Table 1), as
seen in nfya-1mutants described above. As RNAi causes loss of
gene function, the ectopic expression of egl-5 in nfya-1(RNAi)
animals indicates that the ectopic expression of egl-5 is due to
the loss of function of nfya-1.
nfya-1 encodes the C. elegans homolog of NFYA, a
component of the heterotrimeric transcription factor NFY
(Supplemental Figure). The evolutionarily conserved HAP2
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human NFYA (Supplemental Figure). As in NFYA, the N-
terminus of NFYA-1 contains a region that is rich in glutamine
and hydrophobic residues (Coustry et al., 1996). In nfya-1(bp4)and nfya-1(bp5) mutants, a premature stop codon is introduced
at the 102th and the 107th amino acid, respectively, resulting in
the truncation of the C-terminus of NFYA-1, which includes the
HAP2 domain (Supplemental Figure).
Table 1
Expression of egl-5∷gfp in the head region in various genetic backgrounds
Genotype Number of cells
expressing egl-5∷gfp*
n
Wild type 1.4 40
nfya-1(bp4) 23.4 29
nfya-1(RNAi) 12.4 30
nfya-2(RNAi) 1.5 16
nfyb-1(RNAi) 11.5 20
nfyc-1(RNAi) 8.4 25
nfyc-1(RNAi) nfyb-1(RNAi); nfya-1(bp4) 24.2 14
nfya-2(RNAi); nfya-1(bp4) 20.1 15
mes-2/mes-6(RNAi) 12.0 10
mes-2/mes-6(RNAi); nfya-1(bp4) 38.5 40
mes-3(RNAi) 9.4 25
mes-3(RNAi); nfya-1(bp4) 31.5 24
mes-4(RNAi) 0.8 21
mes-4(RNAi); nfya-1(bp4) 22.1 18
*Number of cells expressing egl-5∷gfp was scored in hermaphrodite animals.
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repression
Homologs of other subunits of NFY were identified in the
finished C. elegans genome. W10D9.4 (nfyb-1) and F23F1.1
(nfyc-1) encode the C. elegans homologs of NFYB and NFYC,
respectively. The conserved histone fold motifs (HFM) in
NFYB-1 and NFYC-1 are 65.1% and 44.8%, respectively,
identical to the corresponding human orthologs (Supplemental
Figure). In addition to NFYA-1, Y53H1A.5 (nfya-2) also
encodes a homolog of NFYA, which shows 39.2% identity to
a 215-amino acid region of NFYA-1 (Supplemental Figure).
To determine whether other components of NFY are involved
in Hox gene repression, dsRNA corresponding to each subunit was
injected into egl-5∷gfp reporter strains. We found that egl-5 was
ectopically expressed in nfyb-1(RNAi) and nfyc-1(RNAi) animals
(Table 1; Figs. 1I, J). There were an average number of 11.5 and
8.4 cells in the head region expressing egl-5∷gfp in nfyb-1(RNAi)
and nfyc-1(RNAi) animals, respectively. nfya-2, however, was not
found to be involved in the repression of egl-5 expression (Table
1). Coinjection of dsRNAs of nfyb-1 and nfyc-1 into nfya-1(bp4)
mutants did not further enhance the effect of nfya-1(bp4) on the
ectopic expression of egl-5 (Table 1). nfya-1(bp4) is likely a null
as it deletes the majority of the protein, including the conserved
HAP2 domain. The same extent of defects was observed in the
nfya-1 single mutant animals as was observed in the nfyc-1
(RNAi) nfyb-1(RNAi); nfya-1(bp4) triple mutants, which isFig. 1. Ectopic expression of Hox genes and other developmental defects in nfya-1mu
animal. (B) An nfya-1(bp4)mutant animal ectopically expressing egl-5∷gfp in many
type ray neurons (arrow) and four head neurons (arrowhead) in a wild type male. (D) E
(arrow), indicating that an ectopic ray was generated. (E) Nine sensory rays present in
nfya-1male tail is grossly abnormal. In the male side showed, the development of spi
the fan, adopted the identities of and fused with ray 4 (arrow in red). The male also had
oocytes are found in the proximal site of the gonad (arrow). The distal gonad is ma
contained fewer germ cells. No mature oocytes were formed in the gonad showed. (I–
(RNAi) (I) and an nfyc-1(RNAi) animal (J). (K–L) The mutant egl-5∷gfp reporter,
proximal promoter of egl-5, was ectopically expressed in the head region (marked wconsistent with the explanation that these NFY components
function as part of the same complex in Hox gene regulation.
NFYA-1 and NFYA-2 form two distinct complexes with NFYB-1
and NFYC-1
To determine whether the C. elegans orthologs of the NFY
components form a complex, we examined the interactions
among NFYA-1, NFYA-2, NFYB-1 and NFYC-1 by GST pull-
down experiments. NFYB-1 directly interacted with NFYC-1
(Fig. 2A). Although neither NFYB-1 nor NFYC-1 interacted
with NFYA-1 or NFYA-2, the NFYB-1/NFYC-1 dimer inter-
acted with either 35S-labeled NFYA-1 and 35S NFYA-2 (Figs.
2B, C). Hence, formation of the NFYB-1/NFYC-1 dimer is a
prerequisite for the recruitment of either NFYA-1 or NFYA-2.
The conserved HAP2motif in NFYA-1 was sufficient to mediate
its interaction with NFYB-1/NFYC-1 (Fig. 2D). Thus, two
distinct NFY complexes, containing different NFYA subunits,
may be formed in C. elegans, and these are subsequently named
as the NFYA-1 and NFYA-2 NFY complexes.
The NFY complex binds to probes containing a CCAAT site
NFY has been shown to recognize the CCAAT box with the
preferential (T/C)(A/G)(A/G) 5′ flanking sequence and the C(A/
G) 3′ flanking sequence (Bi et al., 1997). To determine whether
the C. elegans NFY complex has the same DNA-binding
properties as those in other organisms, the DNA-binding activity
of NFY was assessed by electrophoretic mobility shift assay
(EMSA). None of NFYA-2, NFYB-1 or NFYC-1 subunits, or
the NFYB-1/NFYC-1 dimer was able to bind to 32P-labeled egl-
5 promoter probes containing a CCAAT box with the
preferential flanking sequence (Fig. 2F). The NFYA-2/NFYB-
1/NFYC-1 trimer, however, efficiently bound to the probes (Fig.
2F). Mutating the 5′ or 3′ flanking sequence significantly
decreased the binding, while mutating CCAATor both 5′ and 3′
flanking sites nearly abolished the binding of the NFYA-2
complex (Fig. 2G).
The NFYA-1 NFY complex displayed the same DNA-
binding properties as the ones of the NFYA-2 NFY complex
(Fig. 2H). However, unlike the HAP2 domain in other NFYA
subunits, the NFYA-1 HAP2 domain bound directly to DNA
(Fig. 2I). Moreover, the DNA-binding activity of the NFYA-1
HAP2 domain appeared not to be CCAAT dependent (Fig. 2I).
As the NFYA-1 NFY complex specifically binds to the probes
containing the CCAAT box, there must be other domains intants. (A) egl-5∷gfp is absent in the head region (marked with bar) in a wild type
cells in the head region (marked with bar). (C) pkd-2∷gfpmarks nine pairs of B-
ctopic expression of pkd-2∷gfp in the mid-body region in an nfya-1(RNAi)male
a wild type male tail. Each ray has characteristic identity. (F) The morphology of
cule was defective (arrowhead). Ray 3, which normally extends to the margin of
a Lep phenotype (arrow in green). (G) Awild type hermaphrodite gonad. Mature
rked with bar. (H) An nfya-1 hermaphrodite gonad. The gonad was small and
J) Ectopic expression of egl-5 in the head region (marked with bar) in an nfyb-1
carrying a mutated CCAAT site (CTAGC) (C08C3, nt 39,300–39,355) in the
ith bar) (K) and the hypodermal nuclei (marked with bar) (L).
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binding specificity of the NFYA-1 NFY complex.
A CCAAT box in the egl-5 promoter is essential for establishing
the spatially restricted expression pattern of egl-5
Wenext investigated the role of the cognate binding site of the
NFYA-1 complex, CCAAT, in the repression of egl-5. By
analyzing the egl-5 promoter, we identified a CCAATsite that islocated at −86 bp upstream of the translation start site. In vitro
binding assays showed that DNA probes derived from this
region were effectively bound by the NFYA-1 complex (Fig.
2H). We mutated this CCAAT site in the egl-5∷gfp reporter to
CTAGC and examined its expression pattern in stable transgenic
lines. We found that the expression of the mutant egl-5∷gfp
reporter was globally derepressed. There was an average of 9.6
cells (n=28) in the head region expressing egl-5∷gfp (Fig. 1K).
Compared to the average of 23.4 cells expressing egl-5∷gfp in
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cells of the head region could be due to the presence of multiple
CCAAT sites in the promoter and in other genomic regions of
egl-5 also contributing to the repression mediated by the
NFYA-1 complex. Alternatively, NFYA-1 could be repressing
the expression of egl-5 independent of the CCAAT site. The
mutant egl-5∷gfp was also ectopically expressed in the mid-
body region, including the seam cells and the hypodermal nuclei
in both hermaphrodites and males (Fig. 1L). This suggests that
the CCAAT site is essential for establishing the spatially and
temporally specific expression pattern of egl-5 and that the
NFYA-1 complex could directly bind to the egl-5 promoter to
repress its expression. Compared to the expression pattern of
egl-5 in nfya-1 mutants, mutant egl-5∷gfp was more grossly
ectopically expressed in the mid-body region, suggesting that the
disruption of this CCAAT site also affects the binding of other
repressors to the egl-5 promoter, such as the MES-2/MES-6
complex (see below).
The NFYA-1 complex interacts with the MES-2/MES-6 PcG
complex in repressing Hox genes
Mutations in components of theMES-2/MES-6 PcG complex
lead to weak ectopic expression of Hox genes (Ross and
Zarkower, 2003; Zhang et al., 2006). To determine whether the
NFYA-1 complex and the MES-2/MES-6 complex function
together in repressing egl-5, the spatial limits of the ectopic
expression domains of egl-5 in mes-2/mes-6(RNAi); nfya-1
mutants were examined. We found that the number of cells
expressing egl-5 was dramatically increased in mes-2/mes-6
(RNAi); nfya-1 double mutants, especially in males. There was
an average number of 38.5 cells expressing egl-5 in the head
region in mes-2/mes-6(RNAi); nfya-1 mutants, compared with
23.5 and 12.0 in the head region in nfya-1 and mes-2/mes-6
(RNAi) mutants, respectively (Table 1). Moreover, in 70%
(n=30) of mes-2/mes-6(RNAi); nfya-1 mutant males, egl-5 was
ectopically expressed in the mid-body region, including the
seam cells and the hypodermal nuclei, compared to 5% (n=33)
of the nfya-1mutants and 0% (n=20) of the mes-2/mes-6(RNAi)
mutants (Figs. 3A–D). Similarly, the NFYA-1 complex
synergistically interacted with the MES-2/MES-6 complex in
regulating the expression of the Hox gene mab-5 (Fig. 3D).
Consistent with the enhanced ectopic expression of Hox genes
egl-5 and mab-5, the generation of ectopic rays was greatly
increased in mes-2/mes-6(RNAi); nfya-1 mutant males. Twenty
four percent (n=30) ofmales had ectopic rays in double mutants,Fig. 2. Interaction of NFYA-1 or NFYA-2 with NFYB-1/NFYC-1 and the DNA-bindin
1. GST-NFYC-1 fusion proteins were incubated with 35S-labeled NFYB-1. 20% of
Interaction of NFYA-1 (B) or NFYA-2 (C) with NFYB-1 and NFYC-1. 35S-labeled N
NFYB-1 or GST-NFYC-1. (D) The HAP2 domain of NFYA-1 was sufficient to media
experiments. The wild type probe (C08C3, nt 39,378–39,427) contains a CCAAT s
NFYA-2 NFY complex. GST-fusion proteins were incubated with radiolabeled DN
NFYB/C dimer or NFYA-2 could not bind to DNA, while the NFYA-2 NFY complex
complexes, respectively. (G) Role of CCAAT and its flanking sequence in the bindin
nearly abolished the binding, while mutating the 5′ or 3′ flanking sequence decreased t
NFYA-1 NFY complex. The NFYA-1 NFY complex, but not NFYA-1 alone, bound to
abolished the binding activity of the NFYA-1 NFY complex. (I) The NFYA-1 HAP
independent. 1000 ng of proteins was used for each DNA-binding reaction.compared to 2.1% (n=98) in nfya-1 mutants and 0% (n=16) in
mes-2/mes-6(RNAi) mutants (Fig. 3D). The enhancement of the
ectopic expression of egl-5 was also seen in mes-3(RNAi); nfya-
1 mutants (Table 1). MES-3 has been shown to be an integral
component of the MES-2/MES-6 complex (Bender et al., 2004).
However, no such synergistic interactions were observed
between nfya-1(bp4) and a mes-4 mutation (Table 1), consistent
with the fact that MES-4 is not a component of theMES-2/MES-
6 complex.
To determine whether the NFY complex is involved in the
recruitment of the MES-2/MES-6 complex, we examined the
possibility of direct interaction between these two complexes.
GST-NFY proteins were incubated with 35S-labeled MES-2,
MES-3, MES-6 andMES-4. We found that NFYA-1 specifically
bound to MES-3 (Figs. 3E, F). The binding activity in NFYA-1
was further mapped to its HAP2 domain (Fig. 3F), suggesting
that the NFYA-1 complex directly interacted with the MES-2/
MES-6 complex.
The synergistic genetic interaction between the NFYA-1
complex and the MES-2/MES-6 complex, along with the direct
interaction between these two complexes in vitro, indicates that
the NFYA-1 complex and the MES-2/MES-6 complex function
together but also have independent roles in regulating the ex-
pression of Hox genes (see Discussion). Enhancement of the
putative null allele of NFYA-1 in the derepression of egl-5 by
depleting the activity of the MES-2/MES-6 complex also indi-
cates that the NFYA-1 complex contributes to, but is not the sole
factor in, the recruitment of the MES-2/MES-6 complex to the
egl-5 promoter.
nfy is ubiquitously expressed
To determine when and where the nfy genes are expressed in
developing animals, gfp reporters were constructed for each
gene that contains the entire coding sequence, the promoter
region and the 3′UTR, with a gfp inserted at the C-terminus. We
found that NFYA-1 was localized to the nucleus and was
ubiquitously expressed in all nuclei at all developmental stages
(Figs. 4A, B). In larvae and adult animals, strong expression of
nfya-1 was observed in the head ganglia neurons and also in the
developing hermaphrodite vulva and mail tail, while its
expression was lower in most somatic cells (Figs. 4B, C).
nfyb-1 and nfyc-1 displayed identical expression patterns
(Figs. 4D–G and data not shown). NFYB-1 and NFYC-1 were
localized in both the nucleus and the cytoplasm. nfyb-1 and
nfyc-1 were expressed in many cells in the developing embryog activity of the NFY complex. (A) Direct binding betweenNFYB-1 and NFYC-
the 35S-labeled protein used in the binding reactions is shown as input. (B–C)
FYA-1 or NFYA-2 only associated with the NFYB/C dimer, but not with GST-
te the interaction with NFYB/C dimer. (E) Sequence of the probes used in EMSA
ite and the preferential flanking sequence. (F) The DNA-binding activity of the
A probes and the binding activity was assessed by EMSA. NFYB-1, NFYC-1,
bound efficiently to DNA. Arrows and brackets mark probes and protein–DNA
g of the NFYA-2 NFY complex. Mutating CCAAT or both flanking sequences
he binding activity of the NFYA-2 complex. (H) The DNA-binding activity of the
the probe containing a CCAATsite. Mutating CCAATor the flanking sequences
2 domain directly bound to DNA and its DNA-binding activity was CCAAT-
Fig. 3. Synergistic interactions between the NFYA-1 complex and the MES-2/MES-6 complex in regulating the expression of Hox genes. (A–B) Lack of expression of
egl-5∷gfp in the mid-body region in nfya-1 andmes-2/mes-6(RNAi)mutant animals (marked with bar). (C) Dramatically expanded expression domains of egl-5∷gfp in
nfya-1; mes-2/mes-6(RNAi)mutant animals. egl-5∷gfp was ectopically expressed in the mid-body region, including the seam cells and the hypodermal nuclei (marked
with bar). (D) Enhancement of the expression of several reporters, including egl-5∷gfp, mab-5∷gfp, and the ray-specific marker pkd-2∷gfp, in nfya-1, mes-2/mes-6
(RNAi) and mes-2/mes-6(RNAi); nfya-1 mutants. Ectopic expression of mab-5:gfp was observed in 8% (n=50) of nfya-1 mutants and in 3% (n=30) of mes-2/mes-6
(RNAi) mutants, while 47% (n=32) of mes-2/mes-6(RNAi); nfya-1 mutant animals showed ectopic expression of mab-5∷gfp reporter. (E) No interaction between the
NFYA-1 complex andMES-4,MES-2 orMES-6 could be detected. Twenty percent of the 35S-labeled proteins used in the binding reaction is shown as input. A1, B, and
C stand for NFYA-1, NFYB-1, and NFYC-1, respectively. (F) NFYA-1 directly interacted with MES-3. No interaction was detected between 35S MES-3 and GST-
NFYB-1 or GST-NFYC-1. The HAP2 domain in NFYA-1 was sufficient to interact with MES-3.
590 H. Deng et al. / Developmental Biology 308 (2007) 583–592(Fig. 4D). At the larval stages, the expression level of nfyb-1
and nfyc-1 was reduced in most somatic cells except in some
head neurons and in the developing hermaphrodite vulva and
male tail (Figs. 4E–G).
NFYA-2 also localized to the nucleus (Fig. 4H). However,
the expression of nfya-2 was restricted to few tissues, including
the spermatheca, some neurons in the head and other body
regions. Notably, it was highly expressed in intestine cells at all
developmental stages (Fig. 4I). NFYA-2 may constitute a tissue-
specific NFY complex. In summary, nfya-1, nfyb-1 and nfyc-1
were widely expressed in the developing embryo. At post-
embryonic stages, strong expression was limited to the head
ganglia neurons and to tissues that undergo extensive
proliferation and morphogenesis, including the developing
vulva and male tail, which is consistent with the developmental
defects of these tissues in nfya-1 mutants.
Distribution of the CCAAT box in the C. elegans genome
NFY is considered a general promoter organizer in mam-
malian cells and the CCAAT box is one of the most common
elements present in the proximal promoter region of genes. The
analysis of 1031 human genes has shown that the CCAAT box ispresent in 64% of promoters (Suzuki et al., 2001). To determine
whether NFY is also generally required for gene expression inC.
elegans, we examined the distribution of the CCAAT box in C.
elegans promoters. Although the transcription start sites are not
known for most of the genes, previous studies have shown that
the 5′ UTRs of C. elegans genes are usually very short and 57%
of genes are trans-spliced by small leader sequence at the
position very close to the translation start site (Blumenthal and
Steward, 1997). Therefore, we analyzed the regions 200 bp
upstream of the translation start site of the 6513 confirmed C.
elegans genes. We found that the CCAAT box is present in
30.4% of the gene promoters (Supplemental Table), which is
approximately the same frequency as expected from randomly
generated DNA sequence. Therefore, unlike in mammalian
cells, the CCAAT box does not appear to be overrepresented in
the gene promoters in C. elegans.
Discussion
Role of NFY in Hox gene repression in C. elegans
We showed here that mutations in components of the NFYA-
1 NFY complex cause ectopic expression of the Hox gene egl-5.
Fig. 4. Widely expression of Cel-nfy in developing animals. (A–C) Expression of nfya-1∷gfp in developing animals. NFYA-1 was nuclear localized and ubiquitously
expressed in embryos (A) and larvae (B). Strong expression of NFYA-1 was observed in the head (arrowhead) (B), tail region (arrow) (B) and developing vulva
(marked with bar) (C). (D–G) nfyb-1 and nfyc-1 displayed identical expression pattern. nfyc-1 was widely expressed in early developing embryo (four-fold embryo
was shown in panel D) and was localized in both nucleus and cytoplasm (D). At larval stages, nfyb-1 and nfyc-1 were expressed in the head (marked with bar) (E),
developing vulva (marked with bar) (F) and tail region (marked with bar) (G). (H–I) Expression of nfya-2 in developing embryo and early larva. NFYA-2 was nuclear
localized and expressed in a subset of cells at embryonic stages (H). At larval stages, it was expressed in the head region and also concentrated in intestine cells (marked
with bar) (I).
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egl-5 is ectopically expressed only in limited tissues in nfy
mutants. This could be because the transcription factors that
activate the expression of egl-5 in nfy mutants are present, or
active, in only a subset of cells. Alternatively, NFY repression
may be redundant with other repressive mechanisms. For
example, the expression of Hox genes is also known to be
globally repressed by the SOP-2/SOR-1 PcG complex (Zhang et
al., 2003, 2006). egl-5 is ectopically expressed in the head region
in sop-2 and sor-1 mutants as well. At the same time, however,
the NFYA-1 complex and the SOP-2/SOR-1 complex appear to
have different roles in regulating the expression of Hox genes as
mab-5∷gfp is ectopically expressed throughout the body in sop-
2 and sor-1 mutants (Zhang et al., 2003, 2006), while it is only
weakly ectopically expressed in nfya-1 mutants. Nevertheless,
the expression of egl-5 is controlled by multiple repressive
mechanisms, including the NFY complex, the SOP-2/SOR-1
complex and the MES-2/MES-6 complex.
The underlying mechanisms by which the NFYA-1 NFY
complex silences egl-5 have yet to be determined. NFYA-1 is
likely to repress the expression of egl-5 directly by binding to the
CCAAT box present in the proximal promoter of egl-5 as
mutating this CCAAT site also leads to ectopic expression of
egl-5. The binding of the NFYA-1 complex to the egl-5 pro-
moter could further recruit or pre-set the chromatin to potentiatethe binding of other repressors. The MES-2/MES-6 PcG com-
plex is likely to be one of repressors that is directly recruited to
the egl-5 promoter by the NFYA-1 NFY complex as NFYA-1
directly interacts with MES-3 in vitro. The histone H3 methyl-
transferase activity of the MES-2/MES-6 complex may thus
contribute the repression mediated by the NFYA-1 NFY com-
plex. In mammalian cells, HDACs have been shown to be
recruited by the NFY complex in repressing the von Willebrand
factor in non-endothelial cells (Peng and Jahroudi, 2003). egl-5
reporter is also ectopically expressed in hda-1(RNAi) animals
(Zhang, H., unpublished data), suggesting that HDACs could
also be targeted to the egl-5 promoter by the NFYA-1 complex.
In mice, NFY has been shown to activate rather than repress
the expression of Hox4B (Gilthorpe et al., 2002; Zhu et al.,
2005). The DNA elements that mediate the positive effect of
NFY are present in the promoter and an intronic enhancer
(Gilthorpe et al., 2002). The seemingly opposing role of NFY in
regulating the Hox gene expression in C. elegans and mice
could be due to different transcription factors binding to the
NFY sites and modulating the effect of the NFY complex. The
active or repressive role of NFY has been shown to depend on
the interacting cofactors (for a review, see Mantovani, 1999).
NFY has long been thought to be a constitutive and
ubiquitous transcription factor in mammalian cells. Our studies
indicate that the strong expression of nfy is limited in few tissues
592 H. Deng et al. / Developmental Biology 308 (2007) 583–592at post-embryonic stages. In general, they are highly expressed
in cells undergoing proliferation and/or morphogenesis and are
downregulated in differentiated cells, suggesting a role of NFY
in regulating cell division and cell fate specification. Down-
regulation of NFYA has recently been shown in differentiated
hematopoietic stem cells (HSC) (Zhu et al., 2005). To elucidate
the physiological function of NFY in other organisms, a
comparable comprehensive analysis of NFY gene expression
and identification of their in vivo targets is crucial.
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